Iceland - Hospital Average Length of Stay for Malignant Neoplasm of Prostate
Since 2014, Iceland Hospital Average Length of Stay for Malignant Neoplasm of Prostate was down by 4.7% year on year. In 2019, the country was ranked number 12 among other countries in Hospital Average Length of Stay for Malignant Neoplasm of Prostate at 7 Days. Iceland is overtaken by Costa Rica, which was ranked number 11 with 7.2 Days and is followed by Italy at 6.7 Days. South Korea lead the ranking with 15.9 Days in 2019, stable versus 2018. New Zealand, Lithuania and Slovakia respectively ranked number 2, 3 and 4 in this ranking. New Zealand recorded the best 5 years average growth at +2.2% per year, while Mexico was the worst growing country at -8.8% per year.
Loading...
| Date | Days |
|---|---|
| 2019 | 7.00 |
| 2018 | 7.10 |
| 2017 | 6.90 |
| 2016 | 8.10 |
| 2015 |
Download all data from 2000 to 2019
How does Iceland rank in Hospital Average Length of Stay for Malignant Neoplasm of Prostate?
| # | 32 Countries | Days | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
South Korea
|
15.90 | 2019 | +0.0 % | -0.9 % | View data | |
| 2 |
#2
New Zealand
|
11.60 | 2019 | -0.8 % | +2.2 % | View data | |
| 11 |
#11
Costa Rica
|
7.20 | 2019 | +4.3 % | -3.3 % | View data | |
| 12 |
#12
Iceland
|
7.00 | 2019 | -1.4 % | -4.7 % | View data | |
| 13 |
#13
Italy
|
6.70 | 2019 | -1.5 % | -2.0 % | View data | |